Prevalence and Incidence Rates of Atrial Fibrillation in Denmark 2004–2018

References

• Staerk L, Wang B, Preis SR, et al. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018;361:k1453. doi:10.1136/bmj.k1453
   PubMed Web of Science ®Google Scholar
• Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746–2751. doi:10.1093/eurheartj/eht280
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;42(5):373–498.
   Web of Science ®Google Scholar
• Rienstra M, Van Gelder IC. Incidence and outcome of atrial fibrillation: diversity throughout Europe. Eur Heart J. 2021;42:858–860. doi:10.1093/eurheartj/ehaa1078
   Web of Science ®Google Scholar
• Yang PS, Ryu S, Kim D, et al. Variations of prevalence and incidence of atrial fibrillation and oral anticoagulation rate according to different analysis approaches. Sci Rep. 2018;8:6856. doi:10.1038/s41598-018-25111-6
   Web of Science ®Google Scholar
• Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167:1807–1824. doi:10.1016/j.ijcard.2012.12.093
   PubMed Web of Science ®Google Scholar
• Adderley NJ, Ryan R, Nirantharakumar K, Marshall T. Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016. Heart. 2019;105:27–33. doi:10.1136/heartjnl-2018-312977
   PubMed Web of Science ®Google Scholar
• Rodriguez-Manero M, Lopez-Pardo E, Cordero-Fort A, et al. Prevalence and outcomes of atrial fibrillation in a European healthcare area gained through the processing of a health information technology system. Rev Port Cardiol. 2019;38:21–29. doi:10.1016/j.repc.2018.06.008
   Google Scholar
• Marzona I, Proietti M, Vannini T, et al. Sex-related differences in prevalence, treatment and outcomes in patients with atrial fibrillation. Intern Emerg Med. 2020;15:231–240. doi:10.1007/s11739-019-02134-z
   PubMed Web of Science ®Google Scholar
• Schmidt M, Ulrichsen SP, Pedersen L, Botker HE, Nielsen JC, Sorensen HT. 30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death. Int J Cardiol. 2016;225:30–36. doi:10.1016/j.ijcard.2016.09.071
   PubMed Web of Science ®Google Scholar
• Friberg L, Bergfeldt L. Atrial fibrillation prevalence revisited. J Intern Med. 2013;274:461–468. doi:10.1111/joim.12114
   PubMedGoogle Scholar
• Lehto M, Halminen O, Mustonen P, et al. The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics. Eur J Epidemiol. 2022;37:95–102. doi:10.1007/s10654-021-00812-x
   Web of Science ®Google Scholar
• Kjerpeseth LJ, Igland J, Selmer R, et al. Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014. Heart. 2020;107(3):201–207. doi:10.1136/heartjnl-2020-316624
   Web of Science ®Google Scholar
• Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–125. doi:10.1161/CIRCULATIONAHA.105.595140
   PubMed Web of Science ®Google Scholar
• Chamberlain AM, Gersh BJ, Alonso A, et al. Decade-long trends in atrial fibrillation incidence and survival: a community study. Am J Med. 2015;128:260–267. doi:10.1016/j.amjmed.2014.10.030
   Web of Science ®Google Scholar
• Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the. Eur Soc Cardiol. 2011;13:1110–1117.
   Google Scholar
• Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386:154–162. doi:10.1016/S0140-6736(14)61774-8
   PubMed Web of Science ®Google Scholar
• Wodschow K, Bihrmann K, Larsen ML, Gislason G, Ersboll AK. Geographical variation and clustering are found in atrial fibrillation beyond socioeconomic differences: a Danish cohort study, 1987–2015. Int J Health Geogr. 2021;20:11. doi:10.1186/s12942-021-00264-2
   Web of Science ®Google Scholar
• Al-Khayatt BM, Salciccioli JD, Marshall DC, Krahn AD, Shalhoub J, Sikkel MB. Paradoxical impact of socioeconomic factors on outcome of atrial fibrillation in Europe: trends in incidence and mortality from atrial fibrillation. Eur Heart J. 2021;42:847–857. doi:10.1093/eurheartj/ehaa1077
   Web of Science ®Google Scholar
• Copenhagen Healthtech Cluster. The central person registry [Internet]; 2020.
   Google Scholar
• Rix TA, Riahi S, Overvad K, Lundbye-Christensen S, Schmidt EB, Joensen AM. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry. Scand Cardiovasc J. 2012;46:149–153. doi:10.3109/14017431.2012.673728
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish National patient register. Scand J Public Health. 2011;39:30–33. doi:10.1177/1403494811401482
   PubMed Web of Science ®Google Scholar
• Sundboll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ open. 2016;6:e012832. doi:10.1136/bmjopen-2016-012832
   PubMed Web of Science ®Google Scholar
• Engholm G, Ferlay J, Christensen N, et al. NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta oncologica. 2010;49:725–736. doi:10.3109/02841861003782017
   PubMed Web of Science ®Google Scholar
• Hawkins NM, Daniele PR, Humphries KH, et al. Empirical insights when defining the population burden of atrial fibrillation and oral anticoagulation utilization using administrative data. Can J Cardiol. 2019;35:1412–1415. doi:10.1016/j.cjca.2019.05.009
   Web of Science ®Google Scholar
• Ásgeirsdóttir TL, Gerdtham UG. Health behavior in the Nordic countries. Nord J Health Econ. 2016;4:28–40. doi:10.5617/njhe.2717
   Google Scholar
• Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55. doi:10.1016/S0140-6736(16)31919-5
   PubMed Web of Science ®Google Scholar
• Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–2642. doi:10.1016/S0140-6736(17)32129-3
   PubMed Web of Science ®Google Scholar
• Weber C, Hung J, Hickling S, Li I, McQuillan B, Briffa T. Drivers of hospitalisation trends for non-valvular atrial fibrillation in Western Australia, 2000–2013. Int J Cardiol. 2019;276:273–277. doi:10.1016/j.ijcard.2018.09.047
   PubMed Web of Science ®Google Scholar
• Mendonca SC, Saunders CL, Lund J, Mant J, Edwards D. Temporal trends in incidence of atrial fibrillation in primary care records: a population-based cohort study. BMJ Open. 2020;10:e042518. doi:10.1136/bmjopen-2020-042518
   Web of Science ®Google Scholar
• Holt A, Gislason GH, Schou M, et al. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J. 2020;41:3072–3079. doi:10.1093/eurheartj/ehaa494
   PubMed Web of Science ®Google Scholar
• Williams BA, Chamberlain AM, Blankenship JC, Hylek EM, Voyce S. Trends in atrial fibrillation incidence rates within an integrated health care delivery system, 2006 to 2018. JAMA Netw Open. 2020;3:e2014874. doi:10.1001/jamanetworkopen.2020.14874
   PubMed Web of Science ®Google Scholar
• Jones NR, Taylor CJ, Hobbs FDR, Bowman L, Casadei B. Screening for atrial fibrillation: a call for evidence. Eur Heart J. 2020;41:1075–1085. doi:10.1093/eurheartj/ehz834
   PubMed Web of Science ®Google Scholar
• Yao RJR, Andrade JG, Deyell MW, Jackson H, McAlister FA, Hawkins NM. Sensitivity, specificity, positive and negative predictive values of identifying atrial fibrillation using administrative data: a systematic review and meta-analysis. Clin Epidemiol. 2019;11:753–767. doi:10.2147/CLEP.S206267
   PubMed Web of Science ®Google Scholar